Snapshot
Danaher Corp /De/ reported $5.94B of revenue in Q2 2025, up 3.4% year over year, with diluted EPS of $0.77 and an operating margin of 12.8%.
- Revenue
- $5.94B
- YoY growth
- +3.4%
- Diluted EPS
- $0.77
- Operating margin
- 12.8%
$5.94B
Revenue
+3.4%
YoY growth
$0.77
Diluted EPS
12.8%
Operating margin
01 Key takeaways
What management said
- •For more than two decades, we've all benefited from your outstanding financial leadership, your thoughtful guidance, and trusted partnership.
- •Strong growth in our bioprocessing business, paired with disciplined cost management, enabled us to exceed both our adjusted operating profit margin and cash flow expectations for the quarter.
- •Academic and government demand remained soft as expected, with ongoing uncertainty around research funding.
- •We're well-positioned in attractive end markets, driven largely by non-discretionary healthcare needs and supported by strong secular growth drivers.
- •On top of this, our strong balance sheet and free cash flow generation positions us well to further enhance our portfolio going forward.
- •Sales were $5.9 billion in the second quarter, and we delivered 1.5% core revenue growth.
- •Geographically, core revenues in developed markets were up low single-digits, with North America up slightly and a high single-digit increase in Western Europe.
- •Core revenues in high-growth markets were flat overall, as solid performance outside of China was offset by a mid-single-digit decline in China.
- •Growth in our biotechnology and life sciences businesses in China was more than offset by declines in diagnostics due to volume-based procurement and reimbursement changes implemented in late 2024.
- •Our adjusted operating profit margin of 27.3% was flat year-over-year as the favorable impacts of higher volume leverage, product mix, and disciplined cost management were offset by productivity investments to reduce our structural costs.
- •Adjusted diluted net earnings per common share of $1.80 were up approximately 5% year-over-year.
- •We generated $1.1 billion of free cash flow in the quarter and $2.2 billion in the first half of the year, resulting in a year-to-date free cash flow-to-net income conversion ratio of 143%.
SourcesCompany financials · earnings call
Last updated